Lurasidone Effects on Tissue Glutamate in Schizophrenia

Trial Profile

Lurasidone Effects on Tissue Glutamate in Schizophrenia

Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2017

At a glance

  • Drugs Lurasidone (Primary) ; Haloperidol; Perphenazine
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 13 May 2016 Status changed from recruiting to active, no longer recruiting.
    • 29 May 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2016 as reported by record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top